RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas
作者： Zhao-Shi Bao , Hui-Min Chen , Ming-Yu Yang , Chuan-Bao Zhang , Kai Yu
关键词:
摘要: … their nonrecurrent nature are highly reminiscent of RNA-seq efforts in other solid tumor types, … In sum, we reported a comprehensive RNA-seq analysis that characterized the RNA fusion …
core.ac.uk
dissem.in参考文章(51)
則雄 荒木, What's going on 放射線 Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al; European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. N Engl J Med. 2005; 352: 987-96. PMID: 15758009.--神経膠腫に対する治療として、放射線治療とテモゾロマイドの併用が世界的な標準的治療となりうることを示唆する論文 Mebio oncology. ,vol. 3, pp. 132- 134 ,(2006)
Simona Negrini, Vassilis G. Gorgoulis, Thanos D. Halazonetis, Genomic instability — an evolving hallmark of cancer Nature Reviews Molecular Cell Biology. ,vol. 11, pp. 220- 228 ,(2010) , 10.1038/NRM2858
David N. Louis, WHO classification of tumours of the central nervous system International Agency for Research on Cancer. ,(2007)
William D. Foulkes, Tamar Y. Flanders, Pamela M. Pollock, Nicholas K. Hayward, The CDKN2A (p16) gene and human cancer. Molecular Medicine. ,vol. 3, pp. 5- 20 ,(1997) , 10.1007/BF03401664
Alma N. Mohebiany, Roman M. Nikolaienko, Samuel Bouyain, Sheila Harroch, Receptor‐type tyrosine phosphatase ligands: looking for the needle in the haystack FEBS Journal. ,vol. 280, pp. 388- 400 ,(2013) , 10.1111/J.1742-4658.2012.08653.X
J. M. Stommel, A. C. Kimmelman, H. Ying, R. Nabioullin, A. H. Ponugoti, R. Wiedemeyer, A. H. Stegh, J. E. Bradner, K. L. Ligon, C. Brennan, L. Chin, R. A. DePinho, Coactivation of Receptor Tyrosine Kinases Affects the Response of Tumor Cells to Targeted Therapies Science. ,vol. 318, pp. 287- 290 ,(2007) , 10.1126/SCIENCE.1142946
J Bartek, J Bartkova, J Lukas, DNA damage signalling guards against activated oncogenes and tumour progression. Oncogene. ,vol. 26, pp. 7773- 7779 ,(2007) , 10.1038/SJ.ONC.1210881
Kimberly Ng, Ryan Kim, Santosh Kesari, Bob Carter, Clark C. Chen, Genomic profiling of glioblastoma: convergence of fundamental biologic tenets and novel insights. Journal of Neuro-oncology. ,vol. 107, pp. 1- 12 ,(2012) , 10.1007/S11060-011-0714-2
Mark Wade, Yao-Cheng Li, Geoffrey M Wahl, None, MDM2, MDMX and p53 in oncogenesis and cancer therapy. Nature Reviews Cancer. ,vol. 13, pp. 83- 96 ,(2013) , 10.1038/NRC3430
Amit Deshpande, Peter Sicinski, Philip W Hinds, Cyclins and cdks in development and cancer: a perspective Oncogene. ,vol. 24, pp. 2909- 2915 ,(2005) , 10.1038/SJ.ONC.1208618